Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
============================================================================================================================================================

* Saisha A Nalawade
* Paul Shafer
* Pradip Bajgain
* Mary K McKenna
* Arushana Ali
* Lauren Kelly
* Jarrett Joubert
* Stephen Gottschalk
* Norihiro Watanabe
* Ann Leen
* Robin Parihar
* Juan Fernando Vera Valdes
* Valentina Hoyos